Sign Up for Alerts
Sign up to receive receive industry-specific emails from our legal team.
Sign Up for Alerts
We provide tailored, industry-specific legal updates to our clients and other friends of the firm.
Areas of Interest
November 25th, 2025
Game Companies Must be Flexible to Comply with Changing Laws
The panel examined how evolving policy frameworks create new opportunities for developers and platforms navigating global markets .Smizer addressed compliance challenges under emerging laws, specifically citing the Texas App Store Accountability Act. She noted that this kind of legislation changes how developers and platforms interact with users: “App stores have to do this age verification, but so do software and hardware developers. Global compliance is complicated, even just across the states… We’re moving toward a world where you can’t just be willfully ignorant about the age of your users." Her analysis emphasizes a growing trend that age verification and child safety requirements are not only regulatory hurdles but also can create opportunities and growth for businesses and sectors. Read the full summary of the panel here.
Other Quoted
Climate Diaries Cannes Lions 2026
Jeffrey A. Greenbaum is featured in the 51toCarbonZero article, Climate Diaries Cannes Lions 2026, which features eleven interviews with senior leaders from across the media and advertising industry conducted at the Cannes Lions International Festival of Creativity. Read more.
August 5 2026
‘I have been hunted down by HR reps, lawyers, and comms people:’ Developers discuss the pain and prevalence of side work clauses
Wendy Stryker was quoted in a Game Developer article discussing "side work clauses," also known as "moonlighting clauses," in video game industry employment contracts. Read more.
July 30 2026
Experts: Ending Adequate Provision Would Shut Down Prescription Drug Ads
Jeffrey A. Greenbaum was quoted in the Regulatory Affairs Professionals Society (RAPS) article, "Experts: Ending Adequate Provision Would Shut Down Prescription Drug Ads." The article discusses the FDA's proposal to eliminate the "adequate provision" requirement in direct-to-consumer (DTC) prescription drug advertising, a change that experts say could effectively result in a de facto ban on prescription drug advertisements. Read more.
July 21 2026
